In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

MiniMax plans to price its Hong Kong initial public offering at the top of the marketed range, people familiar with the matter said, reflecting investor enthusiasm for Chinese startups that are ...

The Chinese AI startup plans to go public in Hong Kong, positioning itself as a rival to OpenAI. MiniMax aims to raise at least 3.83 billion Hong Kong dollars ($492 million) by selling roughly 25.4 ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, JPMorgan raised Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) from a Neutral ...

MiniMax is set to raise at least HK$4.2 billion (US$537.7 million) by pricing its Hong Kong initial public offering (IPO) at the top of its marketed range, underscoring strong demand for China's ...

CHINESE artificial intelligence (AI) startup MiniMax has secured Alibaba and the Abu Dhabi Investment Authority as key backers in its upcoming initial public offering (IPO) in Hong Kong, said people ...

HONG KONG/SINGAPORE, Jan 5 (Reuters) - MiniMax Group is expected to price its Hong Kong IPO at the top of a marketing range and raise $538 million, three people with knowledge of the deal said, in the ...

The latest news and top stories on Yan Junjie. As CEO of MiniMax, an AI unicorn he founded in December 2021, Yan Junjie leads the development of advanced AI foundational and multimodal models. With ...